Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige mice

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 4, 1996, Pages 1033-1035

  Bermudez, Luiz E ^a   Kolonoski, Peter ^a   Young, Lowell S ^a  

^a Kuzell Institute for Arthritis and Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; LEVOFLOXACIN; ROXITHROMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC SENSITIVITY; BACTERIUM CULTURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MIXTURE; MORTALITY; MOUSE; MYCOBACTERIUM AVIUM; NONHUMAN; NOTE; PRIORITY JOURNAL;

EID: 0029926228     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.4.1033     Document Type: Note

References (23)

1. Bergen, T. 1995. Pharmacokinetics of newer macrolides, p. 51-60. In H C. Neu. L. S. Young, S H. Zinner. and J. F. Acar (ed.), New macrolides. azalides, and streptogramins in clinical practice. Marcel Dekker. Inc , New York.
2. Bermudez, L. E., C. B. Inderlied, P. Kolonoski, M. Petrofsky, and L. S. Young. 1994. Clarithromycin, dapsone, and their combination to treat or prevent disseminated Mycobacterium avium complex in beige mice Antimicrob. Agents Chemother. 38:2717-2722.
3. Bermudez, L. E., C. B. Inderlied, P. Kolonoski, M. Wu, L. Barbara-Burnham, and L. S. Young. 1996. Activity of Bay Y 3118, levofloxacin, and ofloxaein, alone or in combination with ethambutol, against Mycobacterium avium complex in vitro, in human macrophages and beige mice Antimicrob. Agents Chemother. 40:546-551.
4. Bermudez, L. E., M. Petrofsky, and L. S. Young. 1995. Administration of ethambutol in combination with clarithromycin does not prevent selection of clarithromycin-resistat Mycobacterium avium complex, abstr. C96. p. 57. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
5. Bertram, M. A., C. B. Inderlied, S. Yadegar. P. Kolonaski, J. K. Yamada, and L. S. Young. 1986. Confirmation of the beige mouse model for study of disseminated infection with Mycobacterium avium complex. J Infect Dis 154:194-195.
6. Chaisson, R. E., C. A. Benson, M. P. Dube, L. B. Heifets, J. A. Korvick, S. Elkin, T. Smith, J. C. Craft, F. R. Sattler, and A. C. T. Group. 1994 Clarithromycin therapy for bacteremic Mycobacterium avium complex Ann. Intern. Med 121:905-911.
7. Fernandes, P. B., D. J. Hardy, D. McDaniel, C. W. Hanson, and R. N. Swanson. 1989. In vitro and in vivo activities of clarithromycin against Mycobacterium aviton. Antimicrob. Agents Chemother. 33:1531-1536.
8. Fu, K. P., S. C. LaFredo, B. Foleno, D. M. Isaacson, J. F. Barrett, A. J. Topia, and M. E. Rosenthale. 1992. In vitro and in vivo antibacterial activities of levofloxacin (L-ofloxacin) an optically active ofloxacin Antimicrob. Agents Chemother. 36:860-866.
9. Gangadharam, P. R. J. 1995. Beige mouse model for Mycobuctenum avium complex disease Antimicrob. Agents Chemother. 39:1647-1654.
10. Heifets, L. B., P. J. Lindholm-Levy, and R. D. Comstock. 1992. Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium. Am. Rev. Respir. Dis 145:856-858.
11. Inderlied, C., C. A. Kemper, and L. E. Bermudez. 1993. The Mycobactenum avium complex. Clin Microbiol. Rev. 6:266-310.
12. Inderlied, C. B., P. T. Kolonoski, M. Wu, and L. S. Young. 1989. In vitro and in vivo activity of azithromycin (CP 62, 993) against the Mycobacterium avium complex. J. Infect Dis. 159:994-997.
13. Inderlied, C. B., L. S. Young, and J. K. Yamada. 1987. Determination of in vitro susceptibility of Mycobacterium avium complex isolates to antimicrobial agents by various methods. Antimicrob. Agents Chemother. 31:1697-1702
14. Ji, B., N. Lounis, C. Truffot-Pernot, and J. Grosset. 1992. Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapy. Antimiciob. Agents Chemother 36:2839-2840.
15. Kemper, C. A., M. Tze-Chiang, J. Nussbaum, J. Chiu, D. F. Feigal, A. E. Bartok, J. M. Leedom, J. G. Tilles, S. C. Derezinski, A. McCutchan, and the California Collaborative Treatment Group. 1992 Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen: rifampin, ethambutol, clofazimine. and ciprofloxacin. Ann. Intern. Med. 116:466-472
16. Klemens, S. P., M. S. DeStefano, and M. H. Cynamon. 1992. Activity of clarithromycin against Mycobacterium avium complex infection in beige mice Antimicrob. Agents Chemother. 11:2413-2417.
17. Mor, N., J. Vanderkolk, and L. Heifets. 1994. Inhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophages. Antimicrob. Agents Chemother. 38:1161-1164.
18. Rastogi, N., K. S. Goh, and A. Bryskier. 1993. In vitro activity of roxithro-mycin against 16 species of atypical mycobacteria and effect of pH on it radiometric MICs. Antimicrob. Agents Chemother. 37:1560-1562.
19. Rastogi, N., S. G. Khye, and A. Bryskier. 1994 Activities of roxithromycin used alone and in combination with ethambutol, rifampin, amikacin, ofloxacin, and clofazimine against Mycobacterium avium complex. Antimicrob. Agents Chemother. 38:1433-1438
20. Rastogi, N., and V. Labrousse. 1991. Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex. Antimicrob. Agents Chemother. 35:462-470.
21. Struillou, L., Y. Cohen, N. Lounis, G. Bertrand, J. Grosset, J. Vilde, J. Pocidalo, and C. Peronne. 1995 Activities of roxithromycin against Mycobacterium avium infections in human macrophages and C57BL/6 mice. Antimicrob. Agents Chemother. 39:878-881.
22. Young, L. S., L. E. Bermudez, M. Wu, and C. B. Inderlied. 1995. Potential role of roxithromycin against the Mycobacterium avium complex Infection 23:528-533.
23. Young, L. S., L. Wiviott, M. Wu, P. T. Kolonoski, R. Bolan, and C. B. Inderlied. 1991. Azithromycin reduces Mycobacterium avium complex bacteremia and relieves the symptoms of disseminated disease in patients with AIDS Lancet 338:1107-1109.